Revaccination of non- and low- responders after a standard three dose hepatitis B vaccine schedule.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Guangdong province of China is HBV high endemicity and 1.6 million neonates are administrated 5 μg yeast recombinant anti-HBV vaccine each year. But few studies are performed to evaluate the immunogenicity and revaccination effect on non- and low- responders.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Hum Vaccin Immunother

Title: Human vaccines & immunotherapeutics

ISSN (Electronic): 2164-554X

ISSN (Print): 2164-5515

Publication date (Electronic): Dec 1 2012

Volume: 8

Issue: 12

Affiliations

[1 ] Guangdong Center for Disease Control and Prevention, Guangzhou, Guangdong, P.R. China.

Article

Publisher Item ID: 21818

DOI: 10.4161/hv.21818

PMC ID: 3656074

PubMed ID: 22906933

SO-VID: 5481d77f-085e-4420-8d9e-ac162d4c5f77

History

Keywords: hepatitis B vaccine,influence factors,low-responder,non-responder,revaccination

Data availability:

Keywords: hepatitis B vaccine, influence factors, low-responder, non-responder, revaccination

Comments

Comment on this article

scite_

0

Smart Citations

0

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

Cited by 17

See all cited by